Concerto HealthAI racks up $150 mln Series B

Concerto HealthAI, a provider of real-world data and enterprise AI technology solutions for precision oncology, has raised $150 million in Series B financing.

Concerto HealthAI, a provider of real-world data and enterprise AI technology solutions for precision oncology, has raised $150 million in Series B financing. Declaration Partners led the round with participation from Maverick Ventures, AllianceBernstein PCI and SymphonyAI Group. As part of the transaction, Andrew Goldfarb, a partner at Declaration Partners, and Leif Pedersen, a senior operating partner at SymphonyAI Group, will join Concerto HealthAI’s board.

Source: Press Release